Clinicopathological study of the 1973 who classification and the who/isup classification in pta bladder carcinoma

Japanese Journal of Urology

Volumn 101, Issue 4, 2010, Pages 609-614

  Ishida, Ryo ^a   Tsuzuki, Toyonori ^a   Yoshida, Shinri ^a   Shiota, Takako ^a   Nisikimi, Toshinori ^a   Yamada, Hiroshi ^a   Yokoi, Keisuke ^a   Kobayashi, Hiroaki ^a  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

Non muscle invasive bladder carcinoma; Prognostic factor; WHO ISUP classification

Indexed keywords

EID: 77953143028     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol.101.609     Document Type: Article

References (15)

1. Mostfi FK. Sorbin LH and Torioni H: histrogical typing of urinary bladder tumors. International histrogical classification of tumors. No 10, World Health Organization, Genova 1973.
2. Hall MC, Chang SS. Dalbagni G. Pruthi RS, Seigne JD. Skinner EC, Wolf JS Jr and Schellhammer PF: Guideline for the management of nonmuscle invasive bladder cancer (stages Ta T1, and Tis): 2007 update. J Urol., 178 (6), 2314-2330, 2007. (Pubitemid 350080987)
3. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A and Palou-Redorta J; European Association of Urology (EAU): EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol., 54 (2), 303-314, 2008.
4. Eble JN, Sauter G, Epstein JI and Sesterhenn IA: Tumors of the urinary system and male genital organs. World Health Organization Classification of tumors, p 90, IARS press, Lyon, France, 2004.
5. Kakizoe T, Tobisu K, Mizutani T, Tsutsumi M, Tanaka Y and Sakamoto M: Analysis by step sectioning of early invasive bladder cancer with special reference to G3.pT1 disease. Jpn J Cancer Res., 83 (12), 1354-1358, 1992. (Pubitemid 23029845)
6. Dalesio O, Schulman CC, Sylvester R, De Pauw M, Robinson M, Denis L, Smith P and Viggiano G: Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group. J Urol., 129 (4), 730-733, 1983. (Pubitemid 13080873)
7. Fitzpatrick JM, West AB, Butler MR, Lane V and O'Flynn JD: Superficial bladder tumors (stage pTa grades 1 and 2): the importance of recurrence pattern following initial resection. J Urol., 135 (5), 920-922, 1986.
8. Witjes JA, Kiemeney LA, Oosterhof GO and Debruyne FM: Prognostic factors in superficial bladder cancer. A review. Eur Urol., 21 (2), 89-97, 1992.
9. Millán-Rodriguez F, Chéchile-Toniolo G, SalvadorBayarri J, Palou J and Vicente-Rodriguez J: Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol., 163 (1), 73-78, 2000.
10. Epstein JI, Amin MB, Reuter VR and Mostofi FK: The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol., 22 (12), 1435-1448, 1998.
11. Fujii Y, Kawakami S, Koga F, Nemoto T and Kihara K: Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential. BJU Int., 92 (6), 559-562, 2003. (Pubitemid 37271729)
12. Jones TD and Cheng L: Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts. J Urol., 175 (6), 1995-2003, 2006.
13. Holmäng S. Andius P. Hedelin H, Wester K, Busch C and Johansson SL: Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol., 165 (4), 1124-1128, 2001. (Pubitemid 32210217)
14. Samaratunga H, Makarov DV and Epstein JI: Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology., 60 (2), 315-319, 2002. (Pubitemid 34831779)